Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
===================================================================================================================================================================

* Jianghui Tang
* Jianpeng Sheng
* Qi Zhang
* Yongtao Ji
* Xun Wang
* Junlei Zhang
* Jiangchao Wu
* Jinyuan Song
* Xueli Bai
* Tingbo Liang